Hematopoietic cells from gadd45a-deficient and gadd45b-deficient mice exhibit impaired stress responses to acute stimulation with cytokines, myeloablation and inflammation

Oncogene

Volumn 25, Issue 40, 2006, Pages 5537-5546

  Gupta, S K ^a   Gupta, M ^a   Hoffman, B ^a   Liebermann, D A ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Differentiation; Hematopoiesis; Stress

Indexed keywords

CYTOKINE; FLUOROURACIL; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45A; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE LOSS; HEMATOPOIETIC CELL; IN VITRO STUDY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRESS;

ANIMALS; ANTIGENS, DIFFERENTIATION; APOPTOSIS; BLOTTING, NORTHERN; BONE MARROW CELLS; CASEINS; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL SURVIVAL; CYTOKINES; FEMALE; FEMUR; FLUOROURACIL; HEMATOPOIETIC STEM CELLS; INFLAMMATION; MICE; MYELOABLATIVE AGONISTS; MYELOID CELLS; MYELOPOIESIS; NUCLEAR PROTEINS;

EID: 33748414890     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209555     Document Type: Article

References (47)

1. Abdollahi A, Lord KA, Hoffman-Liebermann B, Liebermann DA. (1991). Oncogene 6: 165-167.
2. Amanullah A, Azam N, Balliet A, Hollander C, Hoffman B, Fornace Jr A et al. (2003). Nature 424: 741-742.
3. Asada M, Yamada T, Ichijo H, Delia D, Miyazono K, Fukumuro K et al. (1999). EMBO J 18: 1223-1234.
4. Azam N, Vairapandi M, Zhang W, Hoffman B, Liebermann DA, Azam N et al. (2001). J Biol Chem 276: 2766-2774.
5. Beadling C, Johnson KW, Smith KA. (1993). Proc Natl Acad Sci USA 90: 2719-2723.
6. Cheng T, Rodrigues N, Shen H, Yang Y, Dombkowski D, Sykes M et al. (2000). Science 287: 1804-1808.
7. Daems WT, Koerten HK. (1978). Cell Tissue Res 190: 47-60.
8. De Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin R, Jones J et al. (2001). Nature 414: 308-313.
9. Gupta M, Gupta SK, Balliet AG, Hollander MC, Fornace AJ, Hoffman B et al. (2005). Oncogene 24: 7170-7179.
10. Harkin DP, Bean JM, Miklos D, Song YH, Truong VB, Englert C et al. (1999). Cell 97: 575-586.
11. Hestdal K, Ruscetti FW, Ihle JN, Jacobsen SEW, Dubois CM, Kopp WC et al. (1991). J Immunol 147: 22-28.
12. Hildesheim J, Bulavin DV, Anver MR, Alvord WG, Hollander MC, Vardanian L et al. (2002). Cancer Res 62: 7305-7315.
13. Hoffmeyer A, Piekorz R, Moriggl R, Ihle JN. (2001). Mol Cell Biol 21: 3137-3143.
14. Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmueller L, Shehee R et al. (1999). Nat Genet 23: 176-184.
15. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV et al. (1992). Cell 71: 587-597.
16. Lang R, Patel D, Morris JJ, Rutschman RL, Murray PJ. (2002). J Immunol 169: 2253-2263.
17. Liebermann DA, Hoffman B. (1994). Curr Opin Hematol 1: 24-32.
18. Liebermann DA, Hoffman B. (2003). Blood Cells Mol Dis 31: 213-228.
19. Liebermann DA, Hoffman-Liebermann B. (1989). Oncogene 4: 583-592.
20. Lu B, Ferrandino AF, Flavell RA. (2004). Nat Immunol 5: 38-44.
21. Lu B, Yu H, Chow C, Li B, Zheng W, Davis RJ et al. (2001). Immunity 14: 583-590.
22. Marone M, Bonanno G, Rutella S, Leone G, Scambia G, Pierelli L. (2002). Leukemia Lymphoma 43: 51-57.
23. Metcalf D. (1989). Nature 339: 27-30.
24. Moriggl R, Topham DJ, Teglund S, Sexl V, McKay C, Wang D et al. (1999). Immunity 10: 249-259.
25. Nakahata T, Ogawa M. (1982). Proc Natl Acad Sci USA 79: 3843.
26. Nguyen HQ, Hoffman-Liebermann B, Liebermann DA. (1993). Cell 72: 197-209.
27. Papa S, Zazzeroni F, Bubici C, Jayawardena S, Alvarez K, Matsuda S et al. (2004). Nat Cell Biol 6: 146-153.
28. Platanias LC. (2003). Blood 101: 4467-4479.
29. Randall TD, Weissman IL. (1997). Blood 89: 3596-3606.
30. Richman CM, Weiner RS, Yankee RA. (1976). Blood 47: 1031-1039.
31. Selvakumaran M, Lin HK, Tjin Tham Sjin R, Reed J, Liebermann DA, Hoffman B. (1994). Mol Cell Biol 14: 2352-2360.
32. Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM et al. (1994). Science 266: 1376-1380.
33. Smith ML, Kontny HU, Zhan Q, Sreenath A, O'Connor PM, Fornance Jr AJ. (1996). Oncogene 13: 2255-2263.
34. Takekawa M, Saito H. (1998). Cell 95: 521-530.
35. Takekawa M, Tatebayashi K, Itoh F, Adachi M, Imai K, Saito H. (2002). EMBO J 21: 6473-6482.
36. Taylor PR, Brown GD, Geldhof AB, Martinex-Pomores L, Gordon S. (2003). Eur J Immunol 33: 2090-2097.
37. Teglund S, McKay C, Schuetz E, van Deursen JM, Stravopodis D, Wang D et al. (1998). Cell 93: 841-850.
38. Vairapandi M, Azam N, Balliet AG, Hoffman B, Liebermann DA. (2000). J Biol Chem 275: 16810-16819.
39. Vairapandi M, Balliet AG, Fornance Jr AJ, Hoffman B, Liebermann DA. (1996). Oncogene 12: 2579-2594.
40. Vairapandi M, Balliet AG, Hoffman B, Liebermann DA. (2002). J Cell Physiol 192: 327-338.
41. Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L et al. (1999). Proc Natl Acad Sci USA 96: 3706-3711.
42. Yang J, Zhu H, Murphy TL, Ouyang W, Murphy KM. (2001). Nat Immunol 2: 157-164.
43. Yoo J, Ghiassi M, Jirmanova L, Balliet AG, Hoffman B, Fornace Jr AJ et al. (2003). J Biol Chem 278: 43001-43007.
44. Zazzeroni F, Papa S, Algeciras-Schimnich A, Alvarez K, Melis T, Bubici C et al. (2003). Blood 102: 3270-3279.
45. Zhan Q, Antinore MJ, Wang XW, Carrier F, Smith ML, Harris CC et al. (1999). Oncogene 18: 2892-2900.
46. Zhan Q, Lord KA, Alamo Jr I, Hollander MC, Carrier F, Ron D et al. (1994). Mol Cell Biol 14: 2361-2371.
47. Zhang W, Bae I, Krishnaraju K, Azam N, Fan W, Smith K et al. (1999). Oncogene 18: 4899-4907.